News
Most Read

Boehringer enters into cancer drug development deal with Enara Bio
Healthcare sector could take more than three years to stabilise in the event of no-deal Brexit: Poll
Sentiment about post-Brexit impact on the UK healthcare sector worsens since the onset of COVID-19: Poll

Most Recent

Drug Development

Boehringer enters into cancer drug development deal with Enara Bio

13 Jan 2021
Analysis
Sections

Features
Comment
Projects
Most Read

Genomics and Covid-19: UK’s real-time surveillance system to track viral mutations
Disease-cancelling drugs: Immuneering raises $62m in Series B round
Brazilian data reports modest efficacy for CoronaVac – leading macroeconomic influencers

Most Recent

Big Data

Genomics and Covid-19: UK’s real-time surveillance system to track viral mutations

14 Jan 2021
Sectors
Sections

Clinical Trials
Supply Chain
Drug Development
Manufacturing
Diseases
Cardiovascular
Central Nervous System
Immunology
Infectious Diseases
Oncology
Respiratory
Most Read

GlobalData Epidemiologist Report: Global Covid cases exceed 92 million – UK death count nears 85,000 – worst in Europe
Pharma jobs weekly snapshot: AZ leads the way on hiring in early 2021
Genomics and Covid-19: UK’s real-time surveillance system to track viral mutations

Most Recent

GlobalData Epidemiologist Report: Global Covid cases exceed 92 million – UK death count nears 85,000 – worst in Europe

14 Jan 2021
Themes
Deals
Most Read

Phesi and Sensyne to collaborate on synthetic control arms for clinical trials
Disease-cancelling drugs: Immuneering raises $62m in Series B round
Boehringer enters into cancer drug development deal with Enara Bio

Most Recent

Drug Development

Disease-cancelling drugs: Immuneering raises $62m in Series B round

13 Jan 2021
Companies
Sections

Company A-Z
Company Categories
Product & Services
Company Releases
White Papers
Videos
Most Read

Kiskun Meridian
Baxter BioPharma Solutions
E3D Elcam Drug Delivery Devices

Most Recent

Drug Development

Kiskun Meridian

11 Jan 2021
Magazine
Events

Menu

News
Analysis
Investment
Sectors
Deals
US Election
Disruption
Coronavirus

Partners

Accelerating Clinical Trials
Powder Handling
Simplifying Clinical Trials

Tools

Companies
Reports
Awards
Events
Magazine

The Company

About Us
Contact Us
Advertise With Us
Visit GlobalData

Login
Register

Login
Register

Lonza’s Bioconjugation Facility Expansion, Visp

Lonza announced the expansion of its bioconjugation facility at Visp, Switzerland in December 2020. Credit: Lonza.

Powered by

About Us
Editorial Approach
Contact Us
Terms & Conditions
Privacy Policy

© Copyright 2021 Verdict Media Limited.

Lost Password Back ⟶
Login
Register

Lost Password?

Registration is disabled.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Continue Learn more